- Home
- NRXP vs RDZN Comparison
NRXP vs RDZN Comparison
Compare NRXP & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXP | RDZN |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 75.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | RDZN |
|---|---|---|
| Price | $2.56 | $2.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 519.3K | 156.4K |
| Earning Date | 11-17-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $242,000.00 | ★ $48,035,296.00 |
| Revenue This Year | N/A | $40.39 |
| Revenue Next Year | $821.75 | $64.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.42 |
| 52 Week Low | $1.41 | $0.68 |
| 52 Week High | $6.01 | $2.99 |
Technical Indicators
Market Signals| Indicator | NRXP | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 70.02 |
| Support Level | $1.96 | $1.62 |
| Resistance Level | $2.52 | $2.19 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 93.55 | 77.05 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.